Generics - Teva Pharmaceutical Industries, USA

Filter

Popular Filters

Teva launches generic Baraclude in the USA

Teva launches generic Baraclude in the USA

04-09-2014

Israeli generics giant Teva Pharmaceutical Industries says it has launched its generic equivalent to…

Anti-viralsBaracludeBristol-Myers SquibbGenericsMarkets & MarketingTeva Pharmaceutical IndustriesUSA

EXPERT VIEW: Fewer ‘pay-for-delay’ agreements are likely but they might not disappear altogether

EXPERT VIEW: Fewer ‘pay-for-delay’ agreements are likely but they might not disappear altogether

01-08-2014

The pharmaceutical sector is still reeling from the latest fines imposed by the European Competition…

EuropeEuropean Competition CommissionGenericsInterviewsLegalLupinMylan LaboratoriesPharmaceuticalRegulationServierTeva Pharmaceutical IndustriesUSA

FDA accepts Teva’s NDA for albuterol MDPI

FDA accepts Teva’s NDA for albuterol MDPI

15-07-2014

Israel-based generic giant Teva Pharmaceuticals Industries says that the US Food and Drug Administration…

albuterolExercise-induced bronchospasmGenericsPulmonologyRegulationRespiratory and PulmonaryTeva Pharmaceutical IndustriesUSA

Teva reaches settlement with Perrigo in ProAir HFA patent case

Teva reaches settlement with Perrigo in ProAir HFA patent case

20-06-2014

Israeli generics giant Teva Pharmaceutical Industries has reached a settlement with Perrigo Pharmaceutical…

Catalent Pharma SolutionsGenericsLegalPatents & Trade marksPerrigoProair HFARespiratory and PulmonaryTeva Pharmaceutical IndustriesUSA

Drug pricing power led by hepatitis C, diabetes and cancer

Drug pricing power led by hepatitis C, diabetes and cancer

13-06-2014

Hepatitis C, diabetes and cancer are sustaining high pricing power through innovation according to Morningstar's…

AbbVieAntibiotics and Infectious diseasesBiogen IdecCopaxoneDiabetesGenericsGilead SciencesMerck & CoOncologyPharmaceuticalPricingTecfideraTeva Pharmaceutical IndustriesUSA

US Court denies appeal in Baraclude patent case

US Court denies appeal in Baraclude patent case

13-06-2014

US pharma major Bristol-Myers Squibb yesterday announced that the US Court of Appeals for the Federal…

Anti-viralsBaracludeBristol-Myers SquibbGenericsLegalPatentsTeva Pharmaceutical IndustriesUSA

Actavis settles Nuvigil patent litigation with Cephalon

Actavis settles Nuvigil patent litigation with Cephalon

01-06-2014

Ireland-headquartered generics major Actavis says it has entered into an agreement with Cephalon to settle…

ActavisCephalonGenericsLegalNeurologicalNuvigilPatentsTeva Pharmaceutical IndustriesUSA

US Court rejects Teva’s Copaxone appeal

15-05-2014

A US district court has dismissed a case by Israeli drugmaker Teva Pharmaceutical Industries intended…

CopaxoneGenericsLegalMylanNeurologicalPatentsTeva Pharmaceutical IndustriesUSA

Teva files suit against US FDA over generic Copaxone

Teva files suit against US FDA over generic Copaxone

12-05-2014

Israel-based Teva Pharmaceutical Industries has complained to the US Food and Drug Administration that…

Business FinanceCopaxoneGenericsGlatiramer acetateHealth Medical PharmaLegalNeurologicalScience and technology in IsraelSocial IssuesTeva Pharmaceutical IndustriesUSA

US Supreme Court denies Teva's request for injunction relating to Mylan’s generic Copaxone

21-04-2014

The US Supreme Court Chief Justice Roberts has denied Israeli generics giant Teva Pharmaceutical Industries’…

CopaxoneGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaPatentsTeva Pharmaceutical IndustriesUSA

Teva and Pfizer settle patent litigation over Celebrex

17-04-2014

Israel-based Teva Pharmaceutical Industries says that its US subsidiary has settled a law suit with US…

Anti-Arthritics/RheumaticsCelebrexGenericsNorth AmericaPatentsPfizerTeva Pharmaceutical IndustriesUSA

Teva and Dr Reddy’s latest to launch generic Lunesta in USA

16-04-2014

Two more companies have debuted generic versions of the insomnia drug Lunesta (eszopiclone) tablets,…

Dainippon Sumitomo PharmaDr Reddy's LaboratoriesGenericsLunestaMarkets & MarketingNeurologicalNorth AmericaSunovion PharmaceuticalsTeva Pharmaceutical IndustriesUSA

Teva launches first generic Lovaza in USA

Teva launches first generic Lovaza in USA

08-04-2014

Israel-based Teva Pharmaceutical Industries says it has received US Food and Drug Administration approval…

Cardio-vascularGenericsGlaxoSmithKlineLovazaMarkets & MarketingRegulationTeva Pharmaceutical IndustriesUSA

US District Court upholds Mylan's US patents on Perforomist Inhalation Solution

25-03-2014

US generics major Mylan says the US District Court for the Northern District of West Virginia issued…

GenericsLegalMylan LaboratoriesNorth AmericaPatentsPerforomistRespiratory and PulmonaryTeva Pharmaceutical IndustriesUSA

Teva agrees $27.6 million settlement with US Justice Dept

Teva agrees $27.6 million settlement with US Justice Dept

12-03-2014

US subsidiaries of Israeli generics giant Teva Pharmaceutical Industries have agreed to pay the US government…

ClozapineFinancialGenericsIvaxLegalNeurologicalNorth AmericaTeva Pharmaceutical IndustriesUSA

Teva gains approval for generic Evista in the USA

Teva gains approval for generic Evista in the USA

04-03-2014

Israel-based Teva Pharmaceutical Industries says it has received approval from the US Food and Drug Administration…

Anti-Arthritics/RheumaticsEli LillyEvistaGenericsNorth AmericaRegulationTeva Pharmaceutical IndustriesUSA

Actavis confirms generic Treanda patent challenge

Actavis confirms generic Treanda patent challenge

04-02-2014

US generics drug major Actavis confirms that it has filed an Abbreviated New Drug Application with the…

ActavisCephalonGenericsNorth AmericaOncologyPatentsTeva Pharmaceutical IndustriesTreandaUSA

Teva launches authorized generic of Detrol in USA

Teva launches authorized generic of Detrol in USA

04-01-2014

Israel’s Teva Pharmaceutical Industries, the world’s largest generic drugmaker, says it has launched…

Detrol LAGenericsGenito-urinaryMarkets & MarketingNorth AmericaPfizerTeva Pharmaceutical IndustriesUSA

Back to top